FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
Log in

IQV

IQVIANYSE · Life Sciences Tools & Services · Health Care
Previous close
268.82
Change
−0.85 / −0.32%
FinDog View
Bullish
52-Week Range
154.50 – 273.56
P/E (TTM)
32.3
Forward P/E
20.7
Based on consensus earnings for the next 12 months
Market Cap
$44.2B
1M
+11.43%
S&P 500 −2.41% over same period
Volume / Avg Volume
1.7M / 1.4M
1.20× average

Price History

Closing price · USD1M6M1Y5Y
150200250300FY26 Q2 EarningsFY26 Q1 EarningsFY25 Q4 EarningsFY25 Q3 Earnings2025-092025-122026-032026-062026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 27.11M6M1Y5Y
202530352025-092025-122026-032026-062026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-07-28$4.4B3.15 / 3.06+1.90%Read analysis →
FY2026 Q1
Quarter ended 2026-03
2026-05-05$4.2B2.90 / 2.85+0.03%Read analysis →
FY2025 Q4
Quarter ended 2025-12
2026-02-05—— / —+3.61%Pending
FY2025 Q3
Quarter ended 2025-09
2025-10-28—— / —−0.14%Pending
FY2025 Q2
Quarter ended 2025-06
2025-07-22—— / —+3.66%Pending
FY2025 Q1
Quarter ended 2025-03
2025-05-06—— / —+4.86%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 68 of its 5-year rangeMid-range
5-year range 20.5 – 38.6 · Median 30.0
Last 4 quarters: $1.4B in buybacks + $0 in dividends, 3.21% of market cap combined
P/E (TTM)
32.3
P/B
7.2
P/S
2.6
PEG
1.99
Earnings Reaction
Over the last 6 reports, the stock moved ±2.4% on average on the first trading day after, rising 5 times
Most recent +1.90%
Volatility & Correlation
1-year beta 0.80 · Correlation with S&P 500 0.25Tracks the market
Annualized volatility 41% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 6 · $29.9MNet selling $29.9M
  • 09-02Berkshire James G.See RemarksSell$0.70M2,668 shares · Avg price 261.33
  • 08-03STAUB W RICHARDSee RemarksSell$1.3M5,500 shares · Avg price 232.68
  • 07-31Patel BhavikSee RemarksSell$0.44M1,855 shares · Avg price 235.27
  • 07-29BOUSBIB ARISee RemarksSell$26.1M106,279 shares · 4 trades · Avg price 245.51
  • 07-29Cherofsky KeriannSee RemarksSell$0.14M558 shares · Avg price 245.21
  • 07-29Sherbet EricSee RemarksSell$1.2M5,000 shares · Avg price 249.16
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q14.15+8.4%—0.510.270.621.61
FY2025 Q44.36+10.3%—0.630.510.742.97
FY2025 Q34.10+5.2%—0.550.330.911.93
FY2025 Q24.02+5.3%—0.510.270.441.54
FY2025 Q13.83+2.5%—0.500.250.571.40
FY2024 Q43.96+2.3%—0.630.440.892.41
FY2024 Q33.90+4.3%—0.550.290.721.55
FY2024 Q23.81+2.3%—0.520.360.591.97
FY2024 Q13.74+2.3%—0.510.290.521.56
FY2023 Q43.87+3.5%—0.500.470.752.54
FY2023 Q33.74+4.9%—0.480.300.581.63
FY2023 Q23.73+5.3%—0.520.300.401.59

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
IQVIQVIA$44.2B32.3+8.4%—+11.43%Bullish
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare